2.0(top 20%)
impact factor
434(top 50%)
papers
9.3K(top 20%)
citations
47(top 20%)
h-index
2.3(top 20%)
impact factor
557
all documents
9.6K
doc citations
73(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma FoundationThe Hematology Journal2003374
2The effect of iron deficiency anemia on the function of the immune systemThe Hematology Journal2005204
3Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AMLThe Hematology Journal2003198
4Mesenchymal stem cell: use and perspectivesThe Hematology Journal2003160
5Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myelomaThe Hematology Journal2004129
6Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphomaThe Hematology Journal2004128
7Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myelomaThe Hematology Journal2004126
8Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplantsThe Hematology Journal2001118
9The 5TMM series: a useful in vivo mouse model of human multiple myelomaThe Hematology Journal2000114
10A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphomaThe Hematology Journal2002108
11High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinibThe Hematology Journal2004107
12Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention?The Hematology Journal2004106
13Are myeloma patients with renal failure candidates for autologous stem cell transplantation?The Hematology Journal2000104
14XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosisThe Hematology Journal200495
15Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytomaThe Hematology Journal200192
16Tumor necrosis factor α release is a major biological event associated with rituximab treatmentThe Hematology Journal200188
17Role of coagulation testing in predicting bleeding riskThe Hematology Journal200386
18A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomasThe Hematology Journal200486
19Patterns of mortality in sickle cell disease in adults in France and EnglandThe Hematology Journal200286
20Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma FoundationThe Hematology Journal200386
21Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphomaThe Hematology Journal200083
22A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patientsThe Hematology Journal200180
23Thalidomide in patients with advanced multiple myeloma: a study of 83 patients–report of the intergroupe francophone du myélome (IFM)The Hematology Journal200271
24Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodiesThe Hematology Journal200169
25Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16)The Hematology Journal200269
26Nuclear transplantation, embryonic stem cells and the potential for cell therapyThe Hematology Journal200468
27Antiphospholipid antibodies in lymphoma: prevalence and clinical significanceThe Hematology Journal200464
28Tcf/Lef transcription factors during T-cell development: unique and overlapping functionsThe Hematology Journal200063
29Prognostic significance of FLT3 ITD and D835 mutations in AML patientsThe Hematology Journal200363
30Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?The Hematology Journal200062
31Amplification of a novel c-Kit activating mutation Asn822-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemiaThe Hematology Journal200262
32Disseminated intravascular coagulationThe Hematology Journal200360
33Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomasThe Hematology Journal200357
34Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and WalesThe Hematology Journal200256
35Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V LeidenThe Hematology Journal200055
36The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myelomaThe Hematology Journal200255
37Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxisThe Hematology Journal200355
38Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cellsThe Hematology Journal200254
39Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter studyThe Hematology Journal200451
40Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapyThe Hematology Journal200351
41Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignanciesThe Hematology Journal200050
42Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosisThe Hematology Journal200050
43Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patientsThe Hematology Journal200150
44Antiphospholipid antibodies and thrombosis: strength of associationThe Hematology Journal200350
45Myelodysplastic syndromesThe Hematology Journal200449
46Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further casesThe Hematology Journal200449
47Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathyThe Hematology Journal200148
48Characterisation of TP53 abnormalities in chronic lymphocytic leukaemiaThe Hematology Journal200447
49CD38 expression as a prognostic indicator in chronic lymphocytic leukaemiaThe Hematology Journal200447
50Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cellsThe Hematology Journal200146